The lawsuit, filed in 2013, claimed Teva persuaded physicians to write prescriptions for the drugs Copaxone, a multiple sclerosis treatment, and Azilect, a Parkinson’s drug, by paying them as speakers or consultants. Many of the speaker programs were allegedly sham events.
The lawsuit claimed Teva’s actions violated the False Claims Act and the Anti-Kickback Statute, which prohibit drugmakers from compensating physicians in any way to persuade them to prescribe their drugs.
A spokesperson for Teva told the Philadelphia Business Journal the drugmaker had no comment on the settlement.
Read the full article here.
More articles on pharmacy:
Walgreens secures enterprisewide specialty accreditation
Drug price hike update: Merck, Allergen, Novartis raise prices
Regeneron restructures, cuts at least 15 jobs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
